A Clinical Staging Model for Early Intervention Youth Mental Health Services
Supplemental Material
939_ds001.pdf (204 KB)
The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.
Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.
×939_ds001.pdf (204 KB)
Funding for the headspace project comes from the Australian Government Department of Health and Ageing. The evaluation of these services was supported by an Australia Fellowship (464914) from the National Health and Medical Research Council to Prof. Hickie. Dr. Hermens is supported by a grant from the New South Wales Ministry of Health, Mental Health and Drug and Alcohol Office. Funding agencies had no role in the protocol design, report writing, and the decision to submit the report for publication.
Dr. Hermens has received honoraria from Janssen-Cilag. Dr. Scott has received honoraria from Eli Lilly and Company and Servier and has served on an advisory board for Pfizer. Prof. McGorry has received research funds from AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, and Janssen-Cilag. Prof. Hickie has served as a consultant or advisor for AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Janssen-Cilag, Roche, and Pfizer and has received honoraria from Pfizer, Servier, and AstraZeneca. The other authors report no competing interests.